Long Term Care Journal
Thursday, November 16, 2017
FDA expands approval of Sutent to reduce the risk of kidney cancer returning - FDA Press Releases
FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.
from Food and Drug Administration--Press Releases http://ift.tt/2z7OxsP
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment